Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - BioSource Int'l Inc. (NasdaqNM:BIOI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 21Price hit new 52-week low ($5.05)
Location
542 Flynn Road
Camarillo, CA 93012
Phone: (805) 987-0086
Fax: (805) 388-8295
Email: aspasiaa@biosource.com
Employees (last reported count): 227
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 42%
·Over the last 6 months:
 · 3 insider buys; 91.0K shares (2.1% of insider shares)
·Institutional: 34% (57% of float)
(53 institutions)
·Net Inst. Selling: 933.0K shares (+36.29%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
BioSource International, Inc. develops, manufactures, markets and distributes products used worldwide in biomedical research that are instrumental in the development of new drug therapies and medical diagnostic methods. The Company's products enable scientists and biomedical researchers to better understand the biochemistry, immunology and cell biology of the human body, as well as disease processes. The Company offers over 3,200 products that it groups into Assays; Antibodies; Bioactive Proteins and Peptides; Oligonucleotides, and Serum, Buffers and Media product lines.
More from Market Guide: Expanded Business Description

Financial Summary
Biosource International develops, manufactures, markets and distributes products used in disease related biomedical research and clinical diagnostics, principally in the fields of immunology and molecular biology. For the six months ended 6/30/01, net sales rose 7% to $17.4 million. Net income applicable to Common totaled $524 thousand, up from $20 thousand. Results reflect increased sales in North America, and the absence of $1.5 million in preferred dividends and accretion.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Jean-Pierre Conte, 37
Interim Chairman
--  --  
James Chamberlain, 53
Interim CEO
$350K$1.7M
Charles Best, 41
Exec. VP of Fin., CFO
165K81K
David Thrower, 37
Sr. VP, Global Marketing
--  --  
Cirilo Cabradilla, Ph.D., 53
VP, Molecular Biology
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BIOIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Aug-2001
$5.05 
Recent Price$6.25 
52-Week High
on 22-Sep-2000
$32.50 
Beta1.17 
Daily Volume (3-month avg)51.7K
Daily Volume (10-day avg)46.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-72.3%
52-Week Change
relative to S&P500
-62.8%
Share-Related Items
Market Capitalization$65.3M
Shares Outstanding10.4M
Float6.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.22 
Earnings (ttm)-$0.41 
Earnings (mrq)$0.05 
Sales (ttm)$3.33 
Cash (mrq)$0.98 
Valuation Ratios
Price/Book (mrq)1.48 
Price/EarningsN/A 
Price/Sales (ttm)1.88 
Income Statements
Sales (ttm)$33.3M
EBITDA (ttm)-$1.53M
Income available to common (ttm)-$3.52M
Profitability
Profit Margin (ttm)-3.4%
Operating Margin (ttm)-7.9%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-2.38%
Return on Equity (ttm)-8.70%
Financial Strength
Current Ratio (mrq)4.89 
Debt/Equity (mrq)0 
Total Cash (mrq)$10.2M
Short Interest
As of 8-Aug-2001
Shares Short739.0K
Percent of Float12.1%
Shares Short
(Prior Month)
742.0K
Short Ratio35.19 
Daily Volume21.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.